Literature DB >> 10205220

Mechanisms of immune escape in viral hepatitis.

W Rosenberg1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10205220      PMCID： PMC1727502          DOI： 10.1136/gut.44.5.759

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  78 in total

1.  Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.

Authors:  P Klenerman; S Rowland-Jones; S McAdam; J Edwards; S Daenke; D Lalloo; B Köppe; W Rosenberg; D Boyd; A Edwards
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

Review 2.  Tolerance, danger, and the extended family.

Authors:  P Matzinger
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 3.  Assembly, transport, and function of MHC class II molecules.

Authors:  P Cresswell
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

4.  Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.

Authors:  R Schirmbeck; K Melber; T Mertens; J Reimann
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.

Authors:  R Schirmbeck; K Melber; A Kuhröber; Z A Janowicz; J Reimann
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

6.  Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells.

Authors:  A Bertoletti; A Sette; F V Chisari; A Penna; M Levrero; M De Carli; F Fiaccadori; C Ferrari
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

Review 7.  Antigen analogs/MHC complexes as specific T cell receptor antagonists.

Authors:  A Sette; J Alexander; J Ruppert; K Snoke; A Franco; G Ishioka; H M Grey
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Disquisitions on Original Antigenic Sin. II. Proof in lower creatures.

Authors:  R G Webster
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

9.  Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.

Authors:  R Rotem-Yehudar; S Winograd; S Sela; J E Coligan; R Ehrlich
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

10.  Disquisitions of Original Antigenic Sin. I. Evidence in man.

Authors:  R G Webster
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307
View more
  12 in total

1.  Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.

Authors:  Timothy T Spear; Timothy P Riley; Gretchen E Lyons; Glenda G Callender; Jeffrey J Roszkowski; Yuan Wang; Patricia E Simms; Gina M Scurti; Kendra C Foley; David C Murray; Lance M Hellman; Rachel H McMahan; Makio Iwashima; Elizabeth Garrett-Mayer; Hugo R Rosen; Brian M Baker; Michael I Nishimura
Journal:  J Leukoc Biol       Date:  2016-02-26       Impact factor: 4.962

2.  EBV Latency III-Transformed B Cells Are Inducers of Conventional and Unconventional Regulatory T Cells in a PD-L1-Dependent Manner.

Authors:  Héloïse Auclair; Catherine Ouk-Martin; Lilian Roland; Pauline Santa; Hazar Al Mohamad; Nathalie Faumont; Jean Feuillard; Chantal Jayat-Vignoles
Journal:  J Immunol       Date:  2019-08-21       Impact factor: 5.422

3.  Epidemic spreading under mutually independent intra- and inter-host pathogen evolution.

Authors:  Stefano Boccaletti; Baruch Barzel; Xiyun Zhang; Zhongyuan Ruan; Muhua Zheng; Jie Zhou
Journal:  Nat Commun       Date:  2022-10-20       Impact factor: 17.694

4.  Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity.

Authors:  Kerstin Herzer; Christine S Falk; Jens Encke; Sören T Eichhorst; Axel Ulsenheimer; Barbara Seliger; Peter H Krammer
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection.

Authors:  G C Harcourt; M Lucas; A J Godkin; M Kantzanou; R E Phillips; P Klenerman
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

6.  Human Hepatitis B Virus Negatively Impacts the Protective Immune Crosstalk Between Natural Killer and Dendritic Cells.

Authors:  Teresa Pollicino; Guido Ferlazzo; Claudia De Pasquale; Stefania Campana; Chiara Barberi; Giacomo Sidoti Migliore; Daniela Oliveri; Marika Lanza; Cristina Musolino; Giovanni Raimondo; Soldano Ferrone
Journal:  Hepatology       Date:  2021-05-24       Impact factor: 17.298

7.  Analysis of effect of antiviral therapy on regression of liver fibrosis in patient with HCV infection.

Authors:  Zora Vukobrat-Bijedic; Azra Husic-Selimovic; Lejla Mehinovic; Amila Mehmedovic; Dzelaludin Junuzovic; Ivana Bjelogrlic; Amela Sofic; Aleksandra Djurovic
Journal:  Mater Sociomed       Date:  2014-06-21

8.  Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.

Authors:  Brandon Malone; Boris Simovski; Clément Moliné; Jun Cheng; Marius Gheorghe; Hugues Fontenelle; Ioannis Vardaxis; Simen Tennøe; Jenny-Ann Malmberg; Richard Stratford; Trevor Clancy
Journal:  Sci Rep       Date:  2020-12-23       Impact factor: 4.379

9.  Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.

Authors:  Valeria De Giorgi; Luigi Buonaguro; Andrea Worschech; Maria Lina Tornesello; Francesco Izzo; Francesco M Marincola; Ena Wang; Franco M Buonaguro
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

10.  In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana.

Authors:  Wonderful Tatenda Choga; Motswedi Anderson; Edward Zumbika; Bonolo B Phinius; Tshepiso Mbangiwa; Lynnette N Bhebhe; Kabo Baruti; Peter Opiyo Kimathi; Kaelo K Seatla; Rosemary M Musonda; Trevor Graham Bell; Sikhulile Moyo; Jason T Blackard; Simani Gaseitsiwe
Journal:  Viruses       Date:  2020-07-06       Impact factor: 5.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.